Integrated Diagnostics Biodesix Buy Provides Commercial Path Forward for Indi XL2 Lung Nodule Test Premium The company is confident about bringing the test to market despite potential future competition and views it as an easy fit for its existing sales channels. Biodesix Acquires Integrated Diagnostics The deal gives Biodesix an additional test in the lung cancer space, Indi's XL2, which helps to classify lung nodules identified by imaging scans as benign or malignant. Studies Suggest Challenges Remain for Dried Blood Spot Protein Assays Premium Enthusiasm for dried blood spot samples is building among clinical proteomic researchers and companies, but recent work suggests technical hurdles remain. Industry Pros Suggest Proteomic Dx Technology Ready for Routine Application Premium They acknowledge that while the technical hurdles of proteomic test development have become manageable, commercialization is still a major challenge. Integrated Diagnostics Plans to Launch Second-Gen Xpresys Lung Test in First Half of 2018 Premium With Medicare coverage for the test in place, the company is hoping it will surpass the limited commercial success of its initial Xpresys Lung offering. Aug 1, 2017 Recent Studies Highlight Continued Push Toward Proteomic Lung Cancer Dx Premium Jan 6, 2017 Indi Announces Medicare Coverage for Lung Cancer Test, $6.1M in Series C Funding Dec 23, 2016 Palmetto Releases Draft Coverage Determinations on Several Cancer Molecular Diagnostics Dec 18, 2015 Study Suggests Indi's Xpresys Test Could Reduce Invasive Procedures in NSCLC Diagnosis Premium Jun 26, 2015 Indi Study Finds Significant Overtreatment of Patients With Indeterminate Lung Nodules Premium Apr 17, 2015 Researchers Demonstrate Potential of Indi's PCC Agents to Target 'Undruggable' Proteins Premium Apr 3, 2015 MSACL 2015 Sees Continued Focus on Clinical Proteomics' Calibration, Standardization Challenges Premium Mar 5, 2015 Indi Publishes Details of Assay Variability Controls Used in Xpresys Lung Mass Spec Workflow Premium Feb 5, 2015 Caprion Licenses Indi's Xpresys as Part of Larger Clinical Push Premium Feb 3, 2015 Caprion Takes Licenses to Indi's Xpresys Lung Test Jan 30, 2015 Indi Publishes Second Clinical Validation of Xpresys Lung, Turns Focus to Proving Clinical Utility Premium Jan 2, 2015 For Proteomics, 2014 Marked by Interest, Critiques from the Broader Community Premium Dec 17, 2014 Indi Molecular Collaborating with Sigma-Aldrich on PCC Reagents Nov 7, 2014 Early Interaction with Payors Key to Indi's Success in Winning Coverage for Xpresys Lung Premium Nov 5, 2014 Recent Payor Agreements Give Indi 200M-plus Covered Lives for Xpresys Lung Test May 2, 2014 Integrated Diagnostics Obtains $47M in Funding to Support Commercialization of Xpresys Lung Test Premium May 2, 2014 People in the News: Gustavo Salem, Michael Liang, Charles Wagner Premium Apr 29, 2014 Integrated Diagnostics Obtains $47M in Funding Mar 7, 2014 At MSACL 2014, Advances in MS-based Clinical Proteomics Draws Increased Scrutiny of Field's Methods Premium Dec 10, 2013 Indi Molecular Raises Additional $300K in Seed Funding Load More Breaking News People in the News at Probius, Flagship Biosciences, Discovery Life Sciences, More New Products Posted to GenomeWeb: BillionToOne, Becton Dickinson, Enzo Biochem, More Stroke Risk Contributors, Treatment Targets Uncovered in Cross-Ancestry GWAS In Brief This Week: Yourgene Health, Bionano Laboratories, Caris Life Sciences, More Enzymatic RNA Synthesis Firm EnPlusOne Biosciences Launches With $12M in Seed Funding The Scan Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says. Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds. Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry. UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.